Obese have right to 2 airline seats: Canada court

OTTAWA (Reuters) - Obese people have the right to two seats for the price of one on flights within Canada, the Supreme Court of Canada ruled on Thursday.

The high court declined to hear an appeal by Canadian airlines of a decision by the Canadian Transportation Agency that people who are “functionally disabled by obesity” deserve to have two seats for one fare.

The airlines had lost an appeal at the Federal Court of Appeal in May and had sought to launch a fresh appeal at the Supreme Court. The court’s decision not to hear a new appeal means the one-person-one-fare policy stands.

The appeal had been launched by Air Canada, Air Canada Jazz and WestJet.

(Reporting by Randall Palmer)


Related Posts:

NEW YORK (Reuters) - New York State’s top court on Tuesday rejected a product liability claim against tobacco companies by smokers who said they should have used lower levels of tar and nicotine. The New York State Court of Appeals, in a 6-1 decision, upheld a lower court ruling that found lawyers for smoker Norma Rose

Full Post: Top New York State court rejects cigarette claim

BOSTON (Reuters) - Bristol-Myers Squibb Co said on Tuesday it agreed to pay $1.1 million to settle charges connected with an anti-trust investigation by the New York State Attorney General’s Office, Last year, Bristol-Myers pleaded guilty to two federal criminal counts related to allegations that it illegally concealed a side deal with the generic drugmaker Apotex

Full Post: Bristol-Myers settles Plavix case with states

OTTAWA (Reuters) - One-month-old conjoined twins died on Thursday on board an airliner that was taking them from Europe to the United States for medical treatment, a Canadian newspaper reported. The Halifax Chronicle-Herald said on its website that the Delta Airlines jet had been about 35 minutes off the coast of the Atlantic province of Nova

Full Post: Conjoined twins die on airliner: report

AMSTERDAM (Reuters) - Dutch authorities banned the sale of fresh “magic” mushrooms on Monday, but enforcement was delayed by problems over how to police it. The ban was the latest move by the Netherlands to tighten its famously tolerant policies on drug use, but shops in Amsterdam continued selling the hallucinogenic fungi. “I’ll sell them until they’re

Full Post: Dutch ban magic mushrooms, but “trips” still sold

LONDON (Reuters) - European regulators on Thursday ruled against allowing a patent on developing human embryonic stem cells, a decision that could stifle research by stem cell companies for commercial purposes. An appeal panel at the European Patent Office upheld a June decision to reject a patent application regarding the use of stem cells filed by

Full Post: European agency rules against stem cell patents

Site Navigation

Most Read



  • kinwrite.com@gmail.com